Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

Source:http://linkedlifedata.com/resource/pubmed/id/19942479

Download in:

View as

General Info

PMID
19942479